| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Molecular Biology, Princeton University, Princeton, NJ 08544;
Graduate School of Biotechnology, Korea University, Seoul, South Korea; and
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
promoter. pE-CD1d mice lacked memory-type NKT cells, but, surprisingly, they did not acquire the reciprocal ability to select a diverse population of naive CD1d-restricted cells. These findings suggest that, whereas the development of NKT cells is dependent on the pattern of CD1d expression, the absence of a broad, naive CD1d-restricted T cell repertoire may reflect intrinsic limitations of the pool of TCR genes or lipid Ags. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Recent studies have uncovered other unusual differentiation pathways for autoreactive thymocytes that appear to escape negative selection, such as the acquisition of the so-called CD25+ T regulatory phenotype for some MHC class II-autoreactive T cells (10, 11, 12). There are striking differences, however, between the CD1d-restricted NKT cells and the MHC class II-restricted CD25+CD4+ cells, because the former largely dominate the CD1d-restricted T cell repertoire, whereas the latter represent <5% of the MHC class II-restricted CD4 population. Furthermore, the self-ligands required for the selection of NKT cells are expressed by bone marrow-derived cells, whereas those required for CD25+ regulatory cells can be expressed by epithelial cells (11). Interestingly, other T cells restricted by nonclassical MHC or MHC-like molecules such as Qa1, H2-M3, or MR1 appear to express a memory phenotype. Although autoreactivity has only been demonstrated in the case of MR1-restricted cells, the memory phenotype of all of these T cells restricted by nonclassical MHC-like molecules again correlates with ligand expression on bone marrow-derived cells (13, 14, 15, 16). Altogether, these new findings suggest the intriguing hypothesis that selection by bone marrow-derived cells might ignore thymocytes engaged in low avidity or nonagonist interactions and only rescue those recognizing ligands with higher avidity or agonist properties (17). Such differentiation of memory rather than naive-type cells would ensure quicker responses upon in vivo challenge, straddling innate and adaptive immunity (15).
In this study, we have begun to dissect the influence of the nature of the thymic cell types presenting CD1d ligands on the selection of conventional naive-type vs memory/NKT cells. We reversed the pattern of thymic CD1d expression to that of conventional MHC using the mouse MHC class II E promoter, thus abolishing cortical thymocyte expression of CD1d and promoting epithelial expression. The pE-CD1d mice exhibited a complete loss of NKT cell development. Surprisingly, they also failed to express a detectable population of conventional, naive-type CD1d-restricted cells. These results suggest that NKT cell development requires tissue-specific, cognate interactions with cortical thymocytes rather than with epithelial cells. Furthermore, they demonstrate that the intriguing absence of a significant population of naive-type CD1d-restricted T cells in mice is not a mere consequence of the unique pattern of CD1d expression in the thymus, but may instead reflect intrinsic limitations of the CD1d Ag presentation system, such as a reduced diversity of lipid Ags or of their corresponding TCR repertoire.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice deficient in H2-KbDb (KbDb knockout (KO)), I-A
b (I-Ab KO), CD1d1/CD1d2 (CD1d KO) were used after 9–14 backcrosses onto C57BL/6 (2).
pE-CD1d-transgenic mice were obtained by crossing the transgenic mice expressing CD1d1 under the MHC class II E promoter (described below) with CD1d KO mice. These mice were further crossed to KbDb/CD1d KO and I-Ab/CD1d KO to obtain KbDb KO/pE-CD1d mice and I-Ab KO/pE-CD1d mice, respectively, where the pE-CD1d transgene was expressed in the absence of classical MHC class I or class II and in the absence of endogenous CD1d genes.
All mice were raised in a specific pathogen-free barrier environment at Princeton University according to the institutional animal care and use committee guidelines. Results reported in this study were derived from comparative analysis of littermates of relevant genotypes.
Generation of pE-CD1d-transgenic mice
Full-length C57BL/6 CD1d1 cDNA generated by PCR with forward primer 5'-AAGCGCAGAAGTCGGAGCCG-3' and reverse primer 5'-GCAGGTACGCACATTTGCAGTTGTG-3' was cloned into pCR3.1 (Invitrogen, Carlsbad, CA). The 1.2-kb EcoRI fragment containing mCD1d1 cDNA was inserted at the EcoR1 site in the -globin exon of the pDOI-5 vector (18), which drives gene expression under the control of mouse MHC class II (I-E) promoter. After BglI digestion, a 5-kb fragment containing the E promoter, CD1d1 cDNA, and poly(A) signal as described in Fig. 1 was purified and injected into fertilized C57BL/6 eggs. Four lines of transgene-positive mice were crossed with C57BL/6.CD1d-/- mice to obtain pE-CD1d-transgenic mice.
|
Conjugated mAbs anti-CD3, CD4, CD8, CD24 (HSA), CD45, NK1.1, B220, panTCR, and streptavidin were purchased from BD PharMingen (San Diego, CA). Y3-P anti-I-Ab and 19G11 anti-CD1d were prepared and conjugated to FITC or biotin in our laboratory. Anti-Ly51 (clone 6C3), anti-CD11c, and anti-CD11b were obtained from BD PharMingen. mAb 29 (19) was kindly provided by P. Naquet (Centre d’Immunologie Marseille-Lumigny, Marseille, France). CD1d--galactosylceramide (GalCer) tetramers were produced and used for staining as described previously (20).
Flow cytometry analysis was performed with a four-color FACSort equipped with argon and 635-nm diode lasers (BD Biosciences, Mountain View, CA) and CellQuest software (BD Biosciences).
The following secondary reagents, purchased from Molecular Probes (Eugene, OR) were used for immunohistochemical studies: Alexa Fluor 488 or 568 goat anti-rat IgG, Alexa Fluor 488 or 568 goat anti-hamster IgG, Alexa Fluor 488 goat anti-mouse Ig, and Alexa Fluor 488 or 568-streptavidin.
Frozen section and immunohistochemistry
Thymi were removed and immediately soaked in ice-cold PBS. Unfixed tissues were embedded in OCT freezing medium (Tissue-Tek, Sakura Finetek, CA) and frozen at -80°C until use. Tissue sections (8- to 10-µm thick) were generated with a cryostat and mounted on glass slides (Fisher Scientific, Pittsburgh, PA), air dried, and fixed by immersion into -20°C acetone for 5 min.
For immunohistochemical staining, sections were incubated in PBS with 10% goat serum containing avidin/streptavidin block (Vector Laboratories, Burlingame, CA) for 30 min before incubation with primary Ab for 1 h in humid chamber. Sections were washed with PBS and incubated with the appropriate secondary Ab. For double staining, we used secondary anti-Ig reagents monospecific for rat and hamster. When the other primary mAb (CD11b, 29, or 6C3) was of the same rat origin as the anti-CD1d mAb, we used a biotinylated 19G11 anti-CD1d mAb followed by fluorescent streptavidin in the last steps of the staining process. Y3P anti-I-Ab was used directly conjugated to FITC. Sections were mounted in Mowiol and staining was examined with a confocal microscope Axiovert 100M Zeiss LSM510. Images were processed with Adobe Photoshop 6.0 software (Adobe Systems, Mountain View, CA).
Purification of thymic epithelial cells
Thymic epithelial cells were purified from 6- to 8-wk-old mice that had been irradiated (990 rad) 24–48 h previously. Thymi were cut into small pieces, washed with PBS, and incubated with a mixture of 0.3% trypsin (Sigma-Aldrich, St. Louis, MO) and 0.1% DNase I (Sigma-Aldrich) in PBS at 4°C for 4 h on a rotator. Cells present in suspension were harvested and the remaining fragments were reincubated with fresh trypsin-DNase for 30 min at 37°C and then stirred with fresh trypsin and DNase at room temperature to achieve complete digestion. Cells recovered in suspension were pooled, collected by centrifugation, and resuspended in PBS-1% BSA for flow cytometry analysis.
Generation of liver lymphocytes, thymocytes, splenocytes, DCs, and peritoneal macrophages
Lymphocytes were recovered from thymus, spleen, and liver as previously described (2). Peritoneal macrophages were recovered from peritoneal cavity washes with PBS-10% sucrose. Spleen-derived DCs were obtained by plastic adherence (2 h at 37°C) followed by deadherence of splenocytes and culture for 12–24 h in the presence of GM-CSF (10 ng/ml). Bone marrow-derived DCs were generated by culturing fresh bone marrow cells at 1 x 106 cells/ml in 24-well plates for 7 days in medium supplemented with GM-CSF (5 ng/ml) and IL-4 (5 ng/ml; BioSource International, Camarillo, CA). To induce DC maturation, TNF- (20 ng/ml; BioSource International) was added for the last 18 h of culture.
Ag presentation assay
Briefly, 5 x 105 thymocytes, splenocytes, peritoneal macrophages, or 2 x 105 splenic DCs, immature, or mature bone marrow-derived DCs were plated in 96 flat-bottom microwell plates pulsed with various concentrations of GalCer or medium alone for 6 h, washed, and incubated with 5 x 104 NKT hybridoma DN32.D3 (V14-J18/V8) or TCB11 (V8/V8) for 18–24 h in RPMI 1640 enriched with 10% heat-inactivated FCS, glutamine, antibiotics, and 5 x 10-5 M 2-ME. The IL-2 content of supernatants was measured using the CTLL bioassay (2).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-CD1d mice
We constructed the pE-CD1d transgene by inserting the B6 mouse CD1d1 cDNA into a transgenic expression cassette (Fig. 1). Two of four independent founder lines created in the B6 background had a faithful MHC class II-type pattern of expression, with levels of CD1d in the physiological range, as determined after crossing to B6.CD1d KO mice lacking endogenous CD1d1 and CD1d2. These lines, thereafter referred to as pE-CD1d mice, were selected for further studies. In addition, one pE-CD1d-transgenic line was further crossed with I-Ab/CD1d and KbDb/CD1d doubly and triply deficient mice, respectively, to evaluate transgenic pE-CD1d-restricted selection in the absence of both endogenous CD1d and MHC molecules (see below). Fig. 2 depicts the level of expression of transgenic CD1d molecules in pE-CD1d mice, as quantitated by flow cytometry on various relevant cell types. As expected, CD1d was redistributed among the I-Ab-positive cell types, whereas it was no longer expressed on I-Ab-negative cells. Thus, thymocytes, splenic T cells, and the CD11b+/I-Ab- splenic or peritoneal macrophages, which in wild-type mice express CD1d but are MHC class II negative, lost CD1d expression. Conversely, pE-CD1d was expressed on all I-Ab-expressing cells, including B cells, bone-marrow derived DCs, and splenic CD11b+/I-Ab+ macrophages, and the expression levels achieved with the pE promoter (expressed as mean fluorescence intensity in the relevant quadrants of the dot plots in Fig. 2) were generally very close to, or within a 0.5- to 1.5-fold range of, those observed in wild-type B6 mice. Furthermore, the subset of splenic marginal zone B cells lost the distinctively very high levels of CD1d expression characteristically seen in wild-type mice (21).
|
-CD1d transgene to present exogenous as well as endogenous Ags. Splenocytes and bone-marrow derived mature DCs from wild-type and pE-CD1d mice were pulsed with a range of concentrations of GalCer, the exogenous glycolipid ligand recognized by NKT cells expressing the canonical V14-J18/V8 TCR, and then cultured with the V14-J18/V8 DN32D3 hybridoma. The pE-CD1d APCs elicited strong IL-2 production at levels identical to or slightly above those of wild type (Fig. 3A), closely reflecting the respective surface levels of CD1d measured in Fig. 2. Furthermore, pE-CD1d DCs elicited strong autoreactive responses from both the V14-J18/V8 DN32D3 and the V8/V8 TCB11 hybridomas which recognize distinct endogenous ligands loaded in the endosomal and secretory pathway, respectively (Ref.22 and Fig. 3B).
|
-CD1d mice presented the appropriate pattern of CD1d expression expected from a MHC class II promoter and supported normal Ag-presenting functions.
Expression of pE-CD1d in thymic DCs and epithelium
To quantify surface expression of pE-CD1d in thymic epithelial and DCs, we isolated these cell types from the thymus and analyzed them by flow cytometry in comparison with wild-type and CD1d KO mice examined in the same experiments (Fig. 4). Approximately 11% of thymic cells recovered after in vivo irradiation and in vitro collagenase digestion of the thymus were epithelial cells positive for the MHC class II molecule I-Ab and negative for the hemopoietic marker CD45. Thymic DCs present at low frequency (1.3%) were recognized by their high expression of I-Ab and CD45 (Fig. 4A). Importantly, both thymic epithelial cells and DCs in pE-CD1d mice expressed CD1d on their surface and their level of expression were in the same range (compare Fig. 4, B and C). Surprisingly, we also found that wild-type thymic epithelial cells expressed significant levels of CD1d on their surface, a finding which, to our knowledge, had not been previously reported. In fact, the levels of CD1d in wild-type DCs and epithelial cells were approximately twice those found in pE-CD1d. Because B6 mice heterozygous for the CD1d null mutation (+/-) express half the surface CD1d levels of wild type (+/+) and have normal NKT cells (data not shown), the levels achieved in pE-CD1d mice are considered to be within physiological range. This was further supported by the in situ analysis of CD1d expression in thymic frozen sections showing strong expression by both cortical and medullary epithelial cells as shown below.
|
To further compare the pattern of expression of CD1d and MHC class II molecules in the thymus, we examined frozen tissue sections. In the wild-type thymus, CD1d was broadly expressed on all thymic cells in both the cortical and medullary zones (Fig. 5, upper panels). In contrast, I-Ab expression, which is restricted to epithelial cells, DCs, and macrophages, was scattered in the cortex and abundantly expressed in the medulla. In pE-CD1d mice, CD1d faithfully acquired the MHC class II pattern (Fig. 5, lower panels), as evidenced by the near perfect colocalization of CD1d and I-Ab in the merged picture.
|
-CD1d mice, a significant proportion of macrophages failed to express CD1d (arrows in Fig. 6A, lower panels). This was expected from the MHC II pattern because a proportion of thymic CD11b+ macrophages failed to express I-Ab as well (data not shown). Most CD11c+ DCs expressed CD1d in wild-type as in pE-CD1d mice (Fig. 6B).
|
-CD1d mice (Fig. 7, lower panels). In particular, the strong expression of CD1d in cortical and medullary epithelial cells of pE-CD1d mice mirrored the natural pattern of expression of I-Ab (data not shown) and confirmed the flow cytometry data shown in Fig. 4.
|
-CD1d mice lacked NKT cells
Having established that CD1d was faithfully expressed according to the MHC class II pattern, that its expression levels were within the range of those found in wild-type mice, and that its Ag-presenting functions were conserved, we next examined the selection of CD1d-restricted T cell subsets. Using CD1d-GalCer tetramers, which specifically stain cells expressing the canonical V14-J18/V8 TCRs, we examined their presence in the lymphoid and nonlymphoid tissues. Strikingly, we found that CD1d-GalCer+ cells were undetectable in the thymus, spleen, lymph node, and liver of pE-CD1d mice (Fig. 8). Their frequency, which ranged from 0.1 to 8% in these different tissues in wild-type mice, was <0.01%, the background level in CD1d KO mice. The absence of the V14 T cell lineage was not due to negative selection by the transgenically expressed molecules because mice coexpressing endogenous and transgenic CD1d genes had normal NKT cell frequencies in all tissues examined, including the thymus. Indeed, B6 mice (bearing two copies of the endogenous CD1d genes) that were heterozygous for the pE-CD1d transgene had TCR+NK1.1+ frequencies (percent) of 0.6, 0.6, and 21 in the thymus, spleen, and liver, respectively, over background (in CD1d KO), whereas B6.CD1d+/- littermates that did not express the transgene, and thus had a single copy of endogenous CD1d, had similar frequencies of 0.3, 0.4, and 14. Altogether, these results suggested that positive selection of V14-J18/V8 T cells was entirely abrogated in pE-CD1d mice.
|
-CD1d failed to select conventional CD4 or CD8 T cells
We next investigated whether reverting the pattern of CD1d expression to that of classical MHC class II might "rescue" the selection of a diverse, naive population of T cells. By crossing pE-CD1d mice expressing the transgene but lacking the endogenous CD1d genes with mice lacking both classical MHC class I and CD1d (KbDb/CD1d KO) or classical MHC class II and CD1d (I-Ab/CD1d KO), we eliminated conventional MHC-restricted T cells and directly measured the frequency of residual CD8 or CD4 T cells, respectively, which would include any CD1d-restricted cell selected by pE-CD1d. For comparison, we examined KbDb/CD1d KO or I-Ab/CD1d KO littermates which did not express the transgene. As expected,the control KbDb/CD1d KO and I-Ab/CD1d KO expressed very few residual CD8 or CD4 T cells, respectively, in the thymus (Fig. 9) or in peripheral tissues (Fig. 10). Remarkably, expression of the pE-CD1d transgene failed to rescue a detectable population of either CD8 or CD4 T cells above background. pE-CD1d transgene expression also failed to increase the size of the rare population of CD4-CD8- DN T cells (data not shown). Thus, we conclude that re-expression of CD1d according to the classical MHC class II pattern did not reveal a significant CD1d-restricted repertoire of T cells.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
promoter in CD1d KO mice, we have tested the hypothesis that the marked differences in thymic expression patterns between CD1d and MHC molecules were responsible for the corresponding differences in T cell repertoires. Using flow cytometry, immunohistochemistry, and functional Ag presentation assays, we identified transgenic lines expressing functional CD1d molecules both in the thymus and in peripheral tissues. The relative levels of transgenic CD1d in various cell types tightly reflected those observed for MHC class II, indicating faithful expression of CD1d according to the MHC class II pattern. The levels of CD1d expressed on the surface of thymic epithelial cells, macrophages, DCs, and B cells were within close range (0.5- to 1.5-fold) of those of wild-type mice. Such levels normally support the selection of NKT cells by CD1d when it is driven by its own promoter, because both CD1d+/- mice (where the level of CD1d is 0.5-fold that of +/+) and a CD1d-transgenic line where CD1d expression was driven by its own promoter at levels twice above wild-type exhibited normal NKT cell frequencies (S.-H.P., D.W., and A.B., unpublished data).
In this context, it is remarkable therefore that pE-CD1d mice completely failed to develop CD1d-GalCer tetramer+ V14 T cells. This result seems consistent with previous experiments with bone marrow chimeras, indicating that NKT cell selection required CD1d expression in bone marrow-derived cells, most likely cortical thymocytes (5, 6, 7, 8, 9), as cortical thymocyte expression of CD1d was abolished in our pE-CD1d mice. However, it had not been formerly recognized that CD1d was also expressed by the thymic cortical epithelial cells of normal B6 mice as we have now shown by both immunohistochemistry and FACS analysis. In fact, surface expression of CD1d in B6 mice was as intense in cortical epithelial cells as in cortical thymocytes. In retrospect, this surprising finding indicates that the previously reported lack of NKT cell selection in the CD1d- into CD1d+ bone marrow radiation chimeras must be reinterpreted, as it could not simply be explained by an absence of CD1d expression in the cortical area of the thymus where developing thymocytes undergo positive selection. It is clear that CD1d expression by thymic epithelial cells in these chimeras was not sufficient for selection of NKT cells. One possibility therefore might be that the natural development of NKT cells required a sequence of interactions, first, in the cortex with either cortical thymocytes or epithelial cells and, second, in the medulla or at the corticomedullary junction with bone marrow-derived DCs where the marked expansion and acquisition of the memory phenotype by NKT cells might be induced (3). Such a sequence would be interrupted in the CD1d- into CD1d+ bone marrow radiation chimeras. This scenario was precisely tested and ruled out by the pE-CD1d mice because they expressed CD1d in both cortical epithelial cells and in DCs, yet CD1d-GalCer tetramer+ V14 T cells were absent. Taken together, our results therefore point to some unique nonredundant property of CD1d-expressing cortical thymocytes that is absolutely required for NKT cell development. One possibility is that the level of surface expression of the selecting CD1d-associated ligands, presumably of glycolipid or lipid nature, might be limiting in thymic epithelial cells, perhaps because these ligands are insufficiently generated or processed. Another nonexclusive possibility is that cortical thymocytes might provide additional signals that are specifically required for NKT cell development. For example, NKT cells, which express intrinsically autoreactive TCRs, might normally be deleted unless a specific program, perhaps including the expression of inhibitory NK-like receptors, was activated to down-regulate TCR signaling.
Another major result of our study is that, in the absence of MHC molecules, pE-CD1d mice failed to select naive CD4, CD8, or DN T cells. The genetic approach used in our study allowed for CD1d expression according to the global MHC II pattern in the diverse hemopoietic and nonhemopoietic elements of the thymus, a pattern well known to support the selection, differentiation, and maintenance of naive T cells. Yet, such naive and diverse T cells were conspicuously absent. Much genetic, biochemical, and structural evidence suggests that CD8 acts as a coreceptor for various CD1 family members both in mouse and humans (6, 17, 23, 24, 25, 26), yet no CD8 T cells could be observed above background in KbDb-deficient pE-CD1d mice. A concurrent report of T cell development in a transgenic mouse model where CD1d was expressed under a classical MHC class I promoter and at higher levels than in our pE-CD1d mice confirmed the absence of selection of a naive repertoire of CD8 T cells (30). Given the present demonstration that CD1d is normally expressed by thymic cortical and medullary epithelial cells, previous reports that KbDb KO or TAP KO mice lacked a diverse population of naive CD8 T cells (2) are consistent with the results observed with these new transgenic models. However, the high constitutive levels of CD1d on cortical thymocytes in these KbDb KO or TAP KO mice, which are never observed for classical MHC molecules, might have prevented the selection of naive CD8 T cells (e.g., by inducing negative selection). Therefore, by faithfully reconstituting the MHC pattern of expression, these transgenic mice provided a more accurate model to test whether the differences between the MHC and CD1 pattern of expression were directly responsible for the lack of selection of naive diverse CD8 T cells. We could not detect other non-CD8 T cell subsets either, as shown by the fact that, in I-Ab-deficient pE-CD1d mice, CD4 T cells remained at the residual background level observed in I-Ab/CD1d doubly deficient mice. Finally, there was no increase in the rare DN T cell subset either upon pE-CD1d expression. Altogether, these results demonstrate that expression according to a classical MHC pattern does not confer to CD1d the property to support the development of a diverse and naive T cell repertoire. These surprising findings suggest a fundamental difference between the CD1d and MHC systems, i.e., that, unlike MHC molecules, CD1d molecules may be intrinsically unable to support the development of a diverse naive T cell population. We envision two nonexclusive explanations for this intriguing observation. One possibility is that the lipid ligand repertoire displayed by CD1d in the thymus is highly restricted and cannot support the development of a diverse TCR repertoire. However, although knowledge of the lipid repertoire naturally bound to CD1d is still limited, several reports suggest that a diverse repertoire of endogenous and exogenous lipids is likely to be found associated with CD1d on the cell surface (reviewed in Refs. 27 and 28). The other possibility is that the TCR gene repertoire is intrinsically deficient in CD1d-restricted combinations. We favor this possibility because it seems logical, from an evolutionary point of view, that the majority of the TCR gene pool evolved to recognize MHC-peptide rather than CD1d-lipid complexes, since microbial peptides can mutate at a high rate while lipid changes are rare and often deleterious for bacteria. In addition, we have previously shown that the MHC-restricted repertoire is intrinsically poorly cross-reactive to CD1d (2). Together, these observations might suggest that the MHC- and CD1d-restricted repertoires have evolved under radically different selection pressures and do not overlap. The CD1d-restricted repertoire might be limited and display memory-like features ensuring rapid and forceful innate-type responses, whereas the MHC-restricted repertoire is broad and adaptive.
Our findings should be considered in the broader context of T cell development mediated by the various classical and nonclassical MHC and MHC-like molecules. The emerging picture is that many more T cell developmental pathways exist than previously thought based on the early studies of classical CD4 and CD8 T cells. Several nonclassical MHC or MHC-like molecules such as Qa1, H2-M3, and MR1 are also associated with unusual T cell subsets that are dominated by a memory rather than naive phenotype (13, 14, 15, 16). In all cases, the development of such memory-type cells is mainly supported by bone marrow-derived thymic cells. It is possible that selection on bone marrow-derived cells might ignore thymocytes engaged in low avidity or nonagonist interactions and only rescue those recognizing ligands with higher avidity or agonist properties. The memory phenotype might therefore be imparted by the specificity (i.e., autoreactivity) of the TCR rather than by the restricting element. Bone marrow-derived cells might also support the development of naive type cells, as reported in the case of one MHC-restricted TCR (29). However, because classical MHC molecules are absent or very poorly expressed in cortical thymocytes, the main bone marrow-derived cell type in the cortex, it is difficult at present to assess quantitatively or qualitatively the developmental pathways that they might support if they were abundantly expressed in the bone marrow-derived compartment, e.g., with a CD1d-like pattern. Interestingly, recent studies indicated that epithelial cells could also support the development of memory-type cells, the so-called CD25 T regulatory cells (11). Future studies aiming at unraveling the molecular and cellular basis of these intriguing new developmental pathways should shed light not only on fundamental aspects of T cell development, but also on the functions and evolutionary roles of the various MHC and MHC-like pathways of Ag presentation and their corresponding TCR repertoires.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 C.F. and S.-H.P. contributed equally to this study.
3 Address correspondence and reprint requests to Dr. Albert Bendelac, Department of Pathology, University of Chicago, Room P-309, MC 1089, 5841 South Maryland Avenue, Chicago, IL 60637. E-mail address: abendela{at}bsd.uchicago.edu
4 Abbreviations used in this paper: DN, double negative; GalCer, -galactosylceramide; KO, knockout.
Received for publication May 1, 2003. Accepted for publication August 5, 2003.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
/+ cells in the liver of mice. J. Exp. Med. 180:699.Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  S. Yu and M. T. Cantorna The vitamin D receptor is required for iNKT cell development PNAS, April 1, 2008; 105(13): 5207 - 5212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Chen and A. C. Ross Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells Experimental Biology and Medicine, April 1, 2007; 232(4): 488 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hong, H. Lee, M. Oh, C.-Y. Kang, S. Hong, and S.-H. Park CD4+ T Cells in the Absence of the CD8+ Cytotoxic T Cells Are Critical and Sufficient for NKT Cell-Dependent Tumor Rejection J. Immunol., November 15, 2006; 177(10): 6747 - 6757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schumann, M. P. Mycko, P. Dellabona, G. Casorati, and H. R. MacDonald Cutting Edge: Influence of the TCR Vbeta Domain on the Selection of Semi-Invariant NKT Cells by Endogenous Ligands J. Immunol., February 15, 2006; 176(4): 2064 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Zimmer, A. Colmone, K. Felio, H. Xu, A. Ma, and C.-R. Wang A Cell-Type Specific CD1d Expression Program Modulates Invariant NKT Cell Development and Function J. Immunol., February 1, 2006; 176(3): 1421 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schumann, P. Pittoni, E. Tonti, H. R. MacDonald, P. Dellabona, and G. Casorati Targeted Expression of Human CD1d in Transgenic Mice Reveals Independent Roles for Thymocytes and Thymic APCs in Positive and Negative Selection of V{alpha}14i NKT Cells J. Immunol., December 1, 2005; 175(11): 7303 - 7310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Wei, H. Lee, S.-H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes J. Exp. Med., July 18, 2005; 202(2): 239 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Geng, P. Laslo, K. Barton, and C.-R. Wang Transcriptional Regulation of CD1D1 by Ets Family Transcription Factors J. Immunol., July 15, 2005; 175(2): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Borowski and A. Bendelac Signaling for NKT cell development: the SAP-FynT connection J. Exp. Med., March 21, 2005; 201(6): 833 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Sieling, J. B. Torrelles, S. Stenger, W. Chung, A. E. Burdick, T. H. Rea, P. J. Brennan, J. T. Belisle, S. A. Porcelli, and R. L. Modlin The Human CD1-Restricted T Cell Repertoire Is Limited to Cross-Reactive Antigens: Implications for Host Responses against Immunologically Related Pathogens J. Immunol., March 1, 2005; 174(5): 2637 - 2644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Baldwin, K. A. Hogquist, and S. C. Jameson The Fourth Way? Harnessing Aggressive Tendencies in the Thymus J. Immunol., December 1, 2004; 173(11): 6515 - 6520. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
